One health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
News
Horizon Awards 2025: Max Fisher named as individual winner of Dorothy Jones Award
Max Fisher, a leading Disability & LGBTQIA+ Advocate, and Senior Research Associate at ViaNautis Bio, has been named as individual winner of the Dorothy Jones Diversity & Inclusion Achievement Award 2025.
Read story
NewsPositive signs in the fight against superbugs: CHINET 2024 surveillance report
The 2024 CHINET antimicrobial resistance surveillance report uncovers a hopeful trend in China’s battle against bacterial resistance, with a significant reduction in resistance among several key pathogens.
NewsPathogens are the biggest threats at festivals and mass gatherings
A comprehensive review led by public health experts reveals that infectious disease outbreaks and foodborne illnesses are the most common public health threats at youth-focused mass gatherings, ranging from music festivals and cultural celebrations to sporting and religious gatherings.
NewsLargest study of nose microbiome helps highlight those at risk of staph aureus infection
People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while certain bacteria may help to prevent S. aureus colonisation, according to the findings of the largest-ever study of the nasal microbiome.
More One Health
News
A molecule opens a breach in HIV, providing access to its reservoirs
An international team has unveiled how a molecule capable of opening the “shell” of HIV improves the elimination of infected cells. The study demonstrates how a new CD4-mimetic compound, CJF-III-288, modifies the HIV envelope protein structure to allow for a better immune response.
NewsResearchers rescue antibiotics from resistance using phototherapy
Researchers have used phototherapy to inhibit a protein in E. coli bacteria that makes them resistant to antibiotics. This new method, if proven safe and effective in living organisms, holds promise for rescuing the effectiveness of antibiotics that bacteria have become resistant to.
NewsResearchers identify why some people with HIV achieve remission after antibody treatment
Researchers have discovered why some people living with HIV who are given broadly neutralizing anti-HIV antibodies (bNAbs) can safely stop taking standard, lifelong HIV medications and maintain control of the virus for years, while others given the same treatment do not achieve this remission.
NewsVIRE: a global data platform to better understand viruses
Researchers have released a comprehensive viral genome database covering diverse ecosystems to advance the understanding of viral evolution and ecosystem functions.
NewsThe immune system creates its own targets within viruses
A new study reveals that our immune system does more than defend against viruses. In certain cases, it induces mutations within viruses that make them easier to recognize later on.
NewsBridging controversy: New international guidelines redefine diagnosis and treatment of fungal eye infections
A global expert panel from the Asia-Pacific region has now issued 20 consensus statements providing comprehensive, evidence-based guidance for the diagnosis and management of a sight-threatening condition - fungal endophthalmitis.
NewsPoint-of-care rapid tests can improve screening for latent tuberculosis
A new test shows promising results for detecting latent tuberculosis infection in resource-limited settings. Latent tuberculosis is often diagnosed using a laboratory test called QuantiFERON-TB Gold Plus - this was compared with another test, TB-Feron.
NewsResearchers discover latent antimicrobial resistance across the world
A team of researchers has discovered that latent antimicrobial resistance is more widespread across the world than known resistance. They call for broader surveillance of resistance in wastewater.
NewsHow reactive oxygen species target viruses differently: new clues for safer water disinfection
A new study systematically explored how reactive oxygen species (ROS) inactivate viruses with distinct structures. The results revealed clear heterogeneity: enveloped RNA viruses were most susceptible to oxidation, while double-stranded DNA viruses showed strong resistance.
NewsMucosal virome and host transcriptome interactions reveal viral influence in colorectal polyp development
A new study has provided the first integrated mucosal virome-transcriptome landscape of colorectal polyps, the precursors of colorectal cancer, offering new insights into viral-host interactions at this early disease stage.
NewsPlant extracts show promise in reducing human pathogen risks in agricultural soils
A new study has revealed that natural plant extracts can significantly lower the risks posed by human bacterial pathogens in manure amended agricultural soils. The eco friendly strategy disrupts the communication systems that bacteria use to coordinate harmful activities.
CareersSummer studentship: Oliver probes AMR in neonatal sepsis - and use of novel bacterial screening methods.
Oliver Spiller-Boulter, from Cardiff, reports back on his AMI-sponsored summer studentship which examined antimicrobial resistance (AMR) in neonatal sepsis and the use of novel bacterial screening methods.
NewsCorticosteroid use does not appear to increase infectious complications in non-COVID-19 pneumonia
A systematic review and meta-analysis found that adjunct corticosteroids probably reduce short-term mortality in cases of severe pneumonia and acute respiratory distress syndrome and may reduce secondary shock in severe pneumonia.
NewsTreatment and prevention of HIV/AIDS: infectious disease experts talk unfinished business
As the world marks World AIDS Day, world-renowned infectious disease expert Anthony Fauci, MD, and Greg Folkers, MS, MPH, highlight advances made in the treatment and prevention of HIV, but caution ’History will judge us harshly should we squander this opportunity’.
NewsLong-term HIV control: Could this combination therapy be the key?
A new study shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 million people around the world.
NewsMeasles deaths down 88% since 2000, but cases surge
Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024, according to a new report from the World Health Organization (WHO). Nearly 59 million lives have been saved by the measles vaccine since 2000.
News Lack of dietary iron may impair immune cells’ ability to fight influenza
New research suggests that a lack of dietary iron can negatively affect the ability of immune cells to respond to viral infection in the lungs. In mice with dietary iron deficiency and influenza, immune cells struggled to produce a key signal needed to fight viruses and did not regain this ability.
NewsNew prevention tools and investment in services essential in the fight against AIDS
On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new WHO-approved tools including lenacapavir (LEN) to drive down infections and counter disruption to essential health services caused by cuts to foreign aid.
NewsNobel Prize-awarded material that punctures and kills bacteria
Bacteria that multiply on surfaces are a major headache in healthcare. Researchers have found a new weapon to fight these hotbeds of bacterial growth – metal-organic frameworks. These materials can physically impale, puncture and kill bacteria before they have time to attach to the surface.